Biotechnology Jobs

Basecamp Research · London

Owns the end-to-end sample-to-sequence pipeline for the Trillion Gene Atlas, spanning DNA extraction, library prep and sequencing dispatch across Phase 1 and Phase 2. Bridges R&D and production by scaling validated protocols, applying Lean/Six Sigma to improve throughput, and leading a small lab team while monitoring data return with bioinformatics partners.

Evotec · Abingdon

Owns Evotec's in silico therapeutics design capability, uniting computational chemistry, generative and modality design (small molecules, peptides, protein engineering, degraders, molecular glues) and predictive ADMET/safety under one mandate. A newly created unit within the In Silico & AI group with an explicit build mandate: set technical vision, grow a multi-site team, and industrialise repeatable, benchmarked methods across partner programmes.

Evotec · Abingdon

Acts as the single front door between Global Biology Operations and the In Silico & AI organisation, owning demand, the in silico roadmap and delivery orchestration across computational biology, bioinformatics and AI teams. Focuses on Disease-to-Target and applying the proprietary E.MPD multi-omics resource to target identification, validation and patient stratification, while evidencing value and supporting client proposals.

Relation Therapeutics · London

Lead clinical pharmacology and pharmacometrics across a growing drug discovery portfolio, serving as the quantitative lead on cross-functional project teams. Apply MIDD, PBPK, population PK/PD and QSP modelling to translate nonclinical data into human dosing and trial design, spanning small molecules, biologics and novel platforms. Also manages CRO partnerships and authors regulatory submissions.

Helical · London

Enterprise sales role focused on landing new logos across pharmaceutical and biotech companies, owning the full cycle from prospecting to close. Involves navigating complex multi-stakeholder deals with scientific, technical, procurement and executive buyers, and translating an AI-native biology platform into customer value. Partners closely with founders, product and science teams to refine go-to-market playbooks.

Evotec · Abingdon

Leads Evotec's consolidated AI Accelerator, owning machine learning, generative and agentic AI, and therapeutic hypothesis groups. Sets the AI vision and roadmap, makes build/buy/partner decisions for the AI stack, and turns proprietary multi-omics and experimental data into predictive models and reusable IP. Acts as the senior external technical voice for AI in drug discovery.

Evotec · Abingdon

Acts as the single front door between Evotec's Drug Discovery Platforms and the global In Silico & AI organisation, owning demand, relationships and the in silico roadmap. Translates platform science needs across DMPK, ADME/Tox, predictive safety, screening and omics into prioritised AI requirements, then orchestrates delivery across capability units. Carries a commercial mandate, contributing to client proposals, pricing and evidencing value such as margin uplift and cycle time.